404852008: Palonosetron (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\5-HT3 receptor antagonist\Palonosetron (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\5-HT3 receptor antagonist\Palonosetron (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Palonosetron (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Palonosetron (substance)	Is a	5-HT3 receptor antagonist	true	Inferred relationship	Some
Palonosetron (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	5-HT3 receptor antagonist	true	Inferred relationship	Some
Palonosetron (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Palonosetron (substance)	Is a	Heterocyclic compound	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing palonosetron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Palonosetron hydrochloride (substance)	Is a	False	Palonosetron (substance)	Inferred relationship	Some
Palonosetron 0.25mg/5mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Palonosetron (substance)	Inferred relationship	Some
Product containing netupitant and palonosetron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Netupitant- and palonosetron-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Product containing precisely palonosetron (as palonosetron hydrochloride) 250 microgram/5 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Palonosetron (substance)	Inferred relationship	Some	1
Palonosetron hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Palonosetron (substance)	Inferred relationship	Some
Product containing palonosetron in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Product containing only netupitant and palonosetron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Product containing only palonosetron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Product containing only netupitant and palonosetron in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Palonosetron only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Product containing fosnetupitant and palonosetron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Product containing only fosnetupitant and palonosetron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Product containing fosnetupitant and palonosetron in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Fosnetupitant and palonosetron only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Product containing only fosnetupitant and palonosetron in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Fosnetupitant- and palonosetron-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Palonosetron (substance)	Inferred relationship	Some	1
Palonosetron (as palonosetron hydrochloride) 50 microgram/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Palonosetron (substance)	Inferred relationship	Some	1
Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Palonosetron (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2148682018	Palonosetron (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2156731011	Palonosetron	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
56081000195115	palonosetron	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
830791000172113	palonosétron	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
70231000195114	Palonosetron	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module